Organ-specific features of natural killer cells. Shi FD, Ljunggren HG, La Cava A, Van Kaer L (2011) Nat Rev Immunol 11: 658-71 Reciprocal regulation between natural killer cells and autoreactive T cells. Shi FD, Van Kaer L (2006) Nat Rev Immunol 6: 751-60 Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion. Sosman JA, Stiff P, Moss SM, Sorokin P, Martone B, Bayer R, van Besien K, Devine S, Stock W, Peace D, Chen Y, Long C, Gustin D, Viana M, Hoffman R (2001) J Clin Oncol 19: 634-44 Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta. Arteaga CL, Koli KM, Dugger TC, Clarke R (1999) J Natl Cancer Inst 91: 46-53 Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin. Sosman JA, Kohler PC, Hank JA, Moore KH, Bechhofer R, Storer B, Sondel PM (1988) J Natl Cancer Inst 80: 1451-61 A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens. McCabe RP, Quaranta V, Frugis L, Ferrone S, Reisfeld RA (1979) J Natl Cancer Inst 62: 455-63 The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nishimura T (1999) J Exp Med 189: 1121-8 Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. Williams NS, Moore TA, Schatzle JD, Puzanov IJ, Sivakumar PV, Zlotnik A, Bennett M, Kumar V (1997) J Exp Med 186: 1609-14 Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. Fisch P, Malkovsky M, Braakman E, Sturm E, Bolhuis RL, Prieve A, Sosman JA, Lam VA, Sondel PM (1990) J Exp Med 171: 1567-79 Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. Hao J, Liu R, Piao W, Zhou Q, Vollmer TL, Campagnolo DI, Xiang R, La Cava A, Van Kaer L, Shi FD (2010) J Exp Med 207: 1907-21 Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. Singh AK, Wilson MT, Hong S, Olivares-Villagómez D, Du C, Stanic AK, Joyce S, Sriram S, Koezuka Y, Van Kaer L (2001) J Exp Med 194: 1801-11 Emergence of insulin receptors upon alloimmune T cells in the rat. Helderman JH, Strom TB (1977) J Clin Invest 59: 338-44 Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT (1993) J Clin Invest 92: 2569-76 Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Hong S, Scherer DC, Singh N, Mendiratta SK, Serizawa I, Koezuka Y, Van Kaer L (1999) Immunol Rev 169: 31-44 A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA (1990) Proc Natl Acad Sci U S A 87: 1486-90 Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells. Cook JL, Walker TA, Lewis AM, Ruley HE, Graham FL, Pilder SH (1986) Proc Natl Acad Sci U S A 83: 6965-9 Critical contribution of liver natural killer T cells to a murine model of hepatitis. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K (2000) Proc Natl Acad Sci U S A 97: 5498-503 Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice. Aldrich CJ, Ljunggren HG, Van Kaer L, Ashton-Rickardt PG, Tonegawa S, Forman J (1994) Proc Natl Acad Sci U S A 91: 6525-8 Altered natural killer cell repertoire in Tap-1 mutant mice. Ljunggren HG, Van Kaer L, Ploegh HL, Tonegawa S (1994) Proc Natl Acad Sci U S A 91: 6520-4 Human invariant Valpha24+ natural killer T cells acquire regulatory functions by interacting with IL-10-treated dendritic cells. Yamaura A, Hotta C, Nakazawa M, Van Kaer L, Minami M (2008) Blood 111: 4254-63 Antigen-specific recognition of autologous leukemia cells and allogeneic class-I MHC antigens by IL-2-activated cytotoxic T cells from a patient with acute T-cell leukemia. Fisch P, Weil-Hillman G, Uppenkamp M, Hank JA, Chen BP, Sosman JA, Bridges A, Colamonici OR, Sondel PM (1989) Blood 74: 343-53 NKT cells: T lymphocytes with innate effector functions. Van Kaer L (2007) Curr Opin Immunol 19: 354-64 Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity. Goldstein D, Sosman JA, Hank JA, Weil-Hillman G, Moore KH, Borchert A, Bechhofer R, Storer B, Kohler PC, Levitt D (1989) Cancer Res 49: 6832-9 Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer. Sondel PM, Kohler PC, Hank JA, Moore KH, Rosenthal NS, Sosman JA, Bechhofer R, Storer B (1988) Cancer Res 48: 2561-7 Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens. Curry RA, Quaranta V, Pellegrino MA, Ferrone S (1981) Cancer Res 41: 463-6 Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens. Weil-Hillman G, Fisch P, Prieve AF, Sosman JA, Hank JA, Sondel PM (1989) Cancer Res 49: 3680-8 Natural killer-cell function in hemodialysis patients: effect of the dialysis membrane. Zaoui P, Hakim RM (1993) Kidney Int 43: 1298-305 Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger AB (2010) Clin Cancer Res 16: 2550-61 Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Gelbard A, Garnett CT, Abrams SI, Patel V, Gutkind JS, Palena C, Tsang KY, Schlom J, Hodge JW (2006) Clin Cancer Res 12: 1897-905 Crystallization of free cholesterol in model macrophage foam cells. Kellner-Weibel G, Yancey PG, Jerome WG, Walser T, Mason RP, Phillips MC, Rothblat GH (1999) Arterioscler Thromb Vasc Biol 19: 1891-8 Necroinflammatory liver disease in BALB/c background, TGF-beta 1-deficient mice requires CD4+ T cells. Rudner LA, Lin JT, Park IK, Cates JM, Dyer DA, Franz DM, French MA, Duncan EM, White HD, Gorham JD (2003) J Immunol 170: 4785-92 Critical role of NK1+ T cells in IL-12-induced immune responses in vivo. Kawamura T, Takeda K, Mendiratta SK, Kawamura H, Van Kaer L, Yagita H, Abo T, Okumura K (1998) J Immunol 160: 16-9 Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K (2001) J Immunol 166: 6012-8 Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. Eischen CM, Schilling JD, Lynch DH, Krammer PH, Leibson PJ (1996) J Immunol 156: 2693-9 Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. Adachi K, Tsutsui H, Kashiwamura S, Seki E, Nakano H, Takeuchi O, Takeda K, Okumura K, Van Kaer L, Okamura H, Akira S, Nakanishi K (2001) J Immunol 167: 5928-34 Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii. Tato CM, Villarino A, Caamaño JH, Boothby M, Hunter CA (2003) J Immunol 170: 3139-46 NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. Mühlen KA, Schümann J, Wittke F, Stenger S, Van Rooijen N, Van Kaer L, Tiegs G (2004) J Immunol 172: 3034-41 Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected]. Stanic AK, Shashidharamurthy R, Bezbradica JS, Matsuki N, Yoshimura Y, Miyake S, Choi EY, Schell TD, Van Kaer L, Tevethia SS, Roopenian DC, Yamamura T, Joyce S (2003) J Immunol 171: 4539-51 Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs. Li L, Sullivan BA, Aldrich CJ, Soloski MJ, Forman J, Grandea AG, Jensen PE, Van Kaer L (2004) J Immunol 173: 3707-15
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.